General Pharmacology Practice Questions

Q: Which of the following is a potent microsomal enzyme inducer drug?

Rifampicin. **Explanation:** Microsomal enzyme induction refers to the process where a drug increases the synthesis and activity of cytochrome P450 (CYP450) enzymes in the liver. This leads to an accelerated metabolism of the inducer itself and other co-administered drugs, often resulting in decreased therapeutic efficacy. **Why Rifampicin is correct:** **Rifampicin** is one of the most potent known inducers of the CYP450 system (specifically CYP3A4, 2C9, and 2C19). It acts by binding to the Pregnane X Receptor (PXR), which triggers the transcription of enzyme-coding genes. Clinically, this is significant because it can lead to the failure of drugs like oral contraceptives, warfarin, and anti-retrovirals. **Analysis of Incorrect Options:** * **Captopril (Option A):** An ACE inhibitor used for hypertension. It does not significantly induce or inhibit hepatic microsomal enzymes. * **Erythromycin (Option B):** A macrolide antibiotic that is a well-known **enzyme inhibitor**. It binds to CYP3A4 and prevents the metabolism of other drugs (e.g., theophylline), potentially leading to toxicity. * **Cimetidine (Option D):** An H2-receptor antagonist that is a classic **enzyme inhibitor**. It inhibits multiple CYP isoforms, increasing the levels of drugs like phenytoin and warfarin. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Mnemonic for Enzyme Inhibitors (VITAMINS K):** **V**alproate, **I**soniazid, **T**erfenadine, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**on-DHP CCBs (Verapamil/Diltiazem), **S**ulfonamides, **K**etoconazole/Cimetidine. * **Grapefruit juice** is a potent inhibitor of CYP3A4 in the intestinal wall.

Q: The duration of action of an intravenously administered drug depends on which of the following factors?

All of the above. **Explanation:** The duration of action of a drug is primarily determined by its **elimination half-life ($t_{1/2}$)**, which is the time required for the plasma concentration to reduce by 50%. The relationship is defined by the formula: $$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ 1. **Volume of Distribution ($V_d$):** This represents the extent of drug distribution in the body. A high $V_d$ means the drug is sequestered in tissues, making it less available for elimination organs (liver/kidney), thereby **increasing** the duration of action. 2. **Clearance ($CL$):** This is the efficiency of the body to remove the drug. Higher clearance leads to a shorter half-life and a **shorter** duration of action. 3. **Protein Binding:** This is a crucial determinant of both $V_d$ and $CL$. Only the "free" (unbound) fraction of a drug is pharmacologically active and available for metabolism/excretion. High protein binding acts as a reservoir, slowing down the elimination process and **prolonging** the duration of action. **Why "All of the above" is correct:** Since $V_d$ and $CL$ are the primary physiological determinants of a drug's half-life, and protein binding directly influences both these parameters, all three factors collectively dictate how long a drug remains active in the body. **High-Yield Clinical Pearls for NEET-PG:** * **Redistribution:** For highly lipid-soluble drugs (e.g., **Thiopentone**), the duration of action is determined by redistribution from the brain to fat/muscles, rather than elimination half-life. * **Zero-order kinetics:** Drugs like Phenytoin, Alcohol, and Salicylates have a duration of action that increases disproportionately with dose because their clearance mechanisms saturate. * **Steady State:** It takes approximately **4 to 5 half-lives** to reach a steady-state concentration or to completely eliminate a drug from the body.

Q: Histamine acts on which type of receptors?

G protein coupled receptors. **Explanation:** Histamine is a biogenic amine that exerts its physiological effects by binding to four distinct receptor subtypes: **H1, H2, H3, and H4**. All four of these receptors belong to the **G-protein coupled receptor (GPCR)** superfamily [1], also known as metabotropic receptors. * **H1 receptors** are coupled to **Gq** proteins [3], leading to the activation of phospholipase C and an increase in intracellular calcium (mediating allergy and bronchoconstriction). * **H2 receptors** are coupled to **Gs** proteins [3], increasing cAMP levels (mediating gastric acid secretion). * **H3 and H4 receptors** are coupled to **Gi/o** proteins [3], which inhibit adenylyl cyclase. **Why other options are incorrect:** * **Ligand-gated ion channels:** These involve rapid flux of ions (e.g., Nicotinic ACh, GABA-A, NMDA receptors). Histamine does not directly open ion channels. * **Enzyme-linked receptors:** These possess intrinsic enzymatic activity, such as Tyrosine Kinase (e.g., Insulin, Growth Factor receptors). * **Intracellular receptors:** These are located in the cytoplasm or nucleus and bind lipid-soluble ligands like steroids, thyroxine, and Vitamin D. Histamine is water-soluble and cannot cross the cell membrane. **High-Yield Clinical Pearls for NEET-PG:** * **H1 Antagonists:** Used in allergic rhinitis and motion sickness (e.g., Cetirizine, Promethazine). * **H2 Antagonists:** Used in peptic ulcer disease to reduce acid (e.g., Ranitidine, Famotidine). * **Triple Response of Lewis:** Mediated by histamine, consisting of Red spot (capillary dilation), Flare (arteriolar dilation), and Wheal (exudation). * **H3 receptors** act primarily as presynaptic autoreceptors in the CNS [2], regulating neurotransmitter release.

Q: All of the following statements about mycophenolate mofetil are true except:

It is highly nephrotoxic. ### Explanation **Mycophenolate Mofetil (MMF)** is a potent immunosuppressant widely used in transplant medicine and autoimmune disorders. The correct answer is **D** because MMF is notably **not nephrotoxic**, which distinguishes it from other major immunosuppressants like Calcineurin Inhibitors (CNIs). #### Why Option D is the Correct Answer (The "Except"): Unlike Cyclosporine and Tacrolimus, which cause significant renal vasoconstriction and chronic interstitial fibrosis [1], MMF does not cause kidney damage. In fact, MMF is often used as a "renal-sparing" agent to allow for a reduction in the dose of nephrotoxic CNIs in transplant recipients. #### Analysis of Other Options: * **Option A (True):** MMF is a **prodrug** that is rapidly hydrolyzed in the liver to its active metabolite, **Mycophenolic Acid (MPA)**. * **Option B (True):** **Gastrointestinal (GI) toxicity** is the most common side effect [1]. Patients frequently experience nausea, vomiting, abdominal pain, and diarrhea. This is often the dose-limiting factor in clinical practice. * **Option C (True):** MMF is highly effective and is used as a first-line or rescue therapy in renal, hepatic, and cardiac transplants to prevent acute rejection, especially when other regimens fail or cause intolerable toxicity. #### NEET-PG High-Yield Pearls: * **Mechanism of Action:** It acts as a reversible inhibitor of **Inosine Monophosphate Dehydrogenase (IMPDH)**. This inhibits the *de novo* synthesis of guanosine nucleotides. * **Selectivity:** T and B lymphocytes are highly dependent on the *de novo* pathway (unlike other cells that use the salvage pathway), making MMF a **selective** lymphocyte inhibitor. * **Side Effects:** Apart from GI distress, it causes **myelosuppression** (neutropenia). * **Teratogenicity:** It is contraindicated in pregnancy (Category D) as it can cause "Mycophenolate Embryopathy" (ear and facial abnormalities).

Q: Which of the following is NOT an accepted use of Cyclosporine?

Multiple myeloma. **Explanation:** **Cyclosporine** is a potent immunosuppressant that acts as a **calcineurin inhibitor**. It binds to cyclophilin, forming a complex that inhibits calcineurin, thereby preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This results in the inhibition of IL-2 production and T-cell proliferation. **Why Multiple Myeloma is the Correct Answer:** Multiple myeloma is a **plasma cell malignancy**. The mainstay of treatment involves proteasome inhibitors (Bortezomib), immunomodulators (Lenalidomide), steroids, and alkylating agents. Cyclosporine has no established role in treating plasma cell dyscrasias or hematological malignancies; in fact, long-term immunosuppression with cyclosporine can theoretically increase the risk of secondary lymphomas. **Analysis of Other Options:** * **Organ Transplant:** Cyclosporine revolutionized transplant medicine. It is a first-line agent for preventing graft-versus-host disease (GVHD) and organ rejection in kidney, liver, and heart transplants. * **Rheumatoid Arthritis (RA):** It is used as a Disease-Modifying Antirheumatic Drug (DMARD) in severe, active RA cases that do not respond adequately to methotrexate. * **Recalcitrant Psoriasis:** Due to its T-cell inhibitory action, it is highly effective for severe, plaque-type psoriasis that is resistant to topical therapies or phototherapy. **NEET-PG High-Yield Pearls:** * **Side Effects (Mnemonic: 5 H’s):** **H**irsutism, **H**yperplasia of gums, **H**ypertension, **H**yperlipidemia, and **H**epatotoxicity. * **Nephrotoxicity:** The most common and dose-limiting adverse effect (causes afferent arteriolar vasoconstriction). * **Monitoring:** Requires Therapeutic Drug Monitoring (TDM) due to a narrow therapeutic index. * **Drug Interactions:** Metabolized by CYP3A4; levels increase with Grapefruit juice and Ketoconazole.

Q: Cyclosporin is used as what type of drug?

Immunosuppressant. **Explanation:** **Cyclosporine** is a potent **immunosuppressant** drug primarily used to prevent organ transplant rejection and treat autoimmune conditions. **Why the Correct Answer is Right:** Cyclosporine belongs to the class of **Calcineurin Inhibitors**. Its mechanism of action involves binding to an intracellular protein called **Cyclophilin**. This complex inhibits Calcineurin (a phosphatase), which is essential for the activation of the transcription factor **NFAT** (Nuclear Factor of Activated T-cells). Without NFAT, the transcription of **Interleukin-2 (IL-2)** is blocked, leading to the suppression of T-cell proliferation and the immune response. **Why the Other Options are Incorrect:** * **Anticancer drug:** While some immunosuppressants (like Methotrexate) are used in chemotherapy, Cyclosporine does not have direct cytotoxic or anti-proliferative effects on cancer cells. * **Antibiotic:** Although Cyclosporine was originally isolated from a fungus (*Tolypocladium inflatum*), it lacks significant antimicrobial activity. * **Antiarrhythmic:** Cyclosporine has no therapeutic effect on cardiac rhythm; in fact, it can cause hypertension as a side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Organ transplantation (Kidney, Liver, Heart), Graft-vs-Host disease, Psoriasis, and Rheumatoid Arthritis. * **Adverse Effects (The "H" Rule):** **H**ypertension, **H**irsutism, **H**yperplasia of gums (Gingival Hyperplasia), **H**yperlipidemia, and **H**yperkalemia. * **Nephrotoxicity:** It is the most common and dose-limiting side effect. * **Metabolism:** It is metabolized by **CYP3A4**; therefore, grapefruit juice (inhibitor) increases its toxicity, while Rifampicin (inducer) decreases its efficacy.

Question 1

Which of the following is a potent microsomal enzyme inducer drug?

Accepted Answer

Rifampicin

Answer

Captopril

Answer

Erythromycin

Answer

Cimetidine

Question 2

All the following drugs are inducers of cytochrome P450 enzymes except?

Accepted Answer

Ketoconazole

Answer

Ritonavir

Answer

Chloral hydrate

Answer

Isoniazid

Question 3

A partial agonist can antagonize the effects of a full agonist because it has:

Accepted Answer

High affinity but low intrinsic activity

Answer

Low affinity but high intrinsic activity

Answer

No affinity and low intrinsic activity

Answer

High affinity but no intrinsic activity

Question 4

The duration of action of an intravenously administered drug depends on which of the following factors?

Accepted Answer

All of the above

Answer

Protein binding

Answer

Clearance

Answer

Volume of distribution

Question 5

Histamine acts on which type of receptors?

Accepted Answer

G protein coupled receptors

Answer

Ligand gated ion channels

Answer

Enzyme linked receptors

Answer

Intracellular receptors

Question 6

All of the following statements about mycophenolate mofetil are true except:

Accepted Answer

It is highly nephrotoxic

Answer

It is a prodrug

Answer

Gastrointestinal toxicity is common

Answer

It is used in transplant recipients where other drugs are not effective

Question 7

Which of the following is NOT an accepted use of Cyclosporine?

Accepted Answer

Multiple myeloma

Answer

Organ transplant

Answer

Rheumatoid arthritis

Answer

Recalcitrant psoriasis

Question 8

Nitroglycerine is effective when administered sublingually because it is:

Accepted Answer

Non-ionized and lipid-soluble

Answer

Ionized and lipid-soluble

Answer

Non-ionized and water-insoluble

Answer

Ionized and water-insoluble

Question 9

Cyclosporin is used as what type of drug?

Accepted Answer

Immunosuppressant

Answer

Anticancer drug

Answer

Antibiotic

Answer

Antiarrythmic

Question 10

What is the effect of competitive inhibition on Vmax and Km?

Accepted Answer

Km increased, Vmax unchanged

Answer

Km unchanged

Answer

Vmax increased, Km unchanged

Answer

Km and Vmax increased

General Pharmacology — MCQs

General Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?